Table of Content

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 25
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH APPROACH 28
2.2.1 SECONDARY DATA 29
2.2.1.1 Key data from secondary sources 29
2.2.2 PRIMARY DATA 30
2.2.2.1 Primary sources 31
2.2.2.2 Key data from primary sources 31
2.2.2.3 Key industry insights 32
2.2.2.4 Breakdown of primary interviews 32
2.3 MARKET SIZE ESTIMATION 33
2.3.1 BOTTOM-UP APPROACH 33
2.3.1.1 Approach 1: Company revenue estimation approach 34
2.3.1.2 Approach 2: Presentations of companies and primary interviews 34
2.3.1.3 Growth forecast 34
2.3.1.4 CAGR projections 35
2.3.2 TOP-DOWN APPROACH 35
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.5 MARKET SHARE ASSESSMENT 37
2.6 RESEARCH ASSUMPTIONS 38
2.6.1 PARAMETRIC ASSUMPTIONS 38
2.6.2 GROWTH RATE ASSUMPTIONS 38
2.7 RESEARCH LIMITATIONS 39
2.8 RISK ASSESSMENT 39
3 EXECUTIVE SUMMARY 40
?
4 PREMIUM INSIGHTS 44
4.1 BUNION SURGERY MARKET OVERVIEW 44
4.2 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 44
4.3 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029 45
4.4 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029 45
4.5 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029 46
4.6 BUNION SURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing burden of bunion surgeries 48
5.2.1.2 Expanding geriatric population 48
5.2.1.3 Rising incidence of sports injuries and rheumatoid arthritis 49
5.2.1.4 Growing demand for minimally invasive surgeries 49
5.2.1.5 Increasing research funding and grants 50
5.2.2 RESTRAINTS 50
5.2.2.1 High cost of surgeries 50
5.2.3 OPPORTUNITIES 50
5.2.3.1 Rising number of hospitals and surgical centers worldwide 50
5.2.3.2 Growth opportunities in emerging markets 51
5.2.4 CHALLENGES 52
5.2.4.1 Availability of non-surgical alternatives 52
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 52
5.4 PRICING ANALYSIS 53
5.4.1 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS 53
5.4.2 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION 53
5.4.3 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS,
BY KEY PLAYER 54
5.5 VALUE CHAIN ANALYSIS 54
5.6 SUPPLY CHAIN ANALYSIS 56
5.7 ECOSYSTEM ANALYSIS 57
5.8 INVESTMENT AND FUNDING SCENARIO 58
5.9 TECHNOLOGY ANALYSIS 59
5.9.1 KEY TECHNOLOGIES 59
5.9.1.1 Implants 59
5.9.2 COMPLEMENTARY TECHNOLOGIES 59
5.9.2.1 Correction systems 59
5.9.3 ADJACENT TECHNOLOGIES 59
5.9.3.1 Splints 59
5.10 PATENT ANALYSIS 60
5.11 TRADE ANALYSIS 62
5.11.1 IMPORT DATA FOR HS CODE 9021 62
5.11.2 EXPORT DATA FOR HS CODE 9021 62
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 63
5.13 REGULATORY LANDSCAPE 64
5.13.1 REGULATORY ANALYSIS 64
5.13.1.1 North America 64
5.13.1.1.1 US 64
5.13.1.1.2 Canada 66
5.13.1.2 Europe 67
5.13.1.3 Asia Pacific 68
5.13.1.3.1 China 68
5.13.1.3.2 Japan 69
5.13.1.3.3 India 70
5.13.1.4 Latin America 70
5.13.1.4.1 Brazil 70
5.13.1.4.2 Mexico 70
5.13.1.5 Middle East & Africa 71
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
5.14 PORTER’S FIVE FORCES ANALYSIS 74
5.14.1 THREAT OF NEW ENTRANTS 75
5.14.2 THREAT OF SUBSTITUTES 75
5.14.3 BARGAINING POWER OF BUYERS 75
5.14.4 BARGAINING POWER OF SUPPLIERS 75
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
5.15.2 BUYING CRITERIA 76
5.16 IMPACT OF AI ON BUNION SURGERY MARKET 77
5.16.1 INTRODUCTION 77
5.16.2 MARKET POTENTIAL OF AI 77
5.16.3 AI USE CASES 78
5.16.4 FUTURE OF AI/GEN AI 79
6 BUNION SURGERY MARKET, BY PRODUCT 80
6.1 INTRODUCTION 81
6.2 IMPLANTS & ACCESSORIES 81
6.2.1 SHIFTING DEMOGRAPHIC PATTERN TO FACILITATE GROWTH 81
6.3 CORRECTION SYSTEMS 84
6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
TO DRIVE MARKET 84
7 BUNION SURGERY MARKET, BY PATIENT TYPE 88
7.1 INTRODUCTION 89
7.2 ADULT PATIENTS 89
7.2.1 CHANGING LIFESTYLE PREFERENCES TO PROMOTE GROWTH 89
7.3 PEDIATRIC PATIENTS 92
7.3.1 INCREASING PREVALENCE OF FLAT FEET AND CEREBRAL PALSY
TO AID GROWTH 92
8 BUNION SURGERY MARKET, BY TYPE 95
8.1 INTRODUCTION 96
8.2 TRADITIONAL SURGERIES 96
8.2.1 RISING POOL OF ARTHRITIS PATIENTS TO EXPEDITE GROWTH 96
8.3 MINIMALLY INVASIVE SURGERIES 99
8.3.1 GROWING ADVANCEMENTS IN SPECIALIZED SURGICAL TOOLS
TO FUEL MARKET 99
9 BUNION SURGERY MARKET, BY END USER 103
9.1 INTRODUCTION 104
9.2 HOSPITALS 104
9.2.1 INCREASING DEMAND FOR SPECIALIZED TREATMENTS TO SUSTAIN GROWTH 104
9.3 AMBULATORY SURGERY CENTERS 107
9.3.1 RISING INCLINATION TOWARD LOWER COSTS AND SHORTER PATIENT STAYS TO STIMULATE GROWTH 107
9.4 ORTHOPEDIC CLINICS 109
9.4.1 GROWING PREFERENCE FOR EFFECTIVE POST-OPERATIVE CARE AND LIMITED HOSPITALIZATION TO BOOST MARKET 109
10 BUNION SURGERY MARKET, BY REGION 113
10.1 INTRODUCTION 114
10.2 NORTH AMERICA 114
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118
10.2.2 US 118
10.2.2.1 Increasing number of FDA approvals to facilitate growth 118
10.2.3 CANADA 120
10.2.3.1 Growing incidence of arthritis to promote growth 120
10.3 EUROPE 122
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 124
10.3.2 GERMANY 125
10.3.2.1 Increasing incidence of osteoporosis to expedite growth 125
10.3.3 UK 127
10.3.3.1 Growing demand for surgical treatments to drive market 127
10.3.4 FRANCE 129
10.3.4.1 Presence of robust healthcare system to augment growth 129
10.3.5 ITALY 131
10.3.5.1 Growing geriatric population to fuel market 131
10.3.6 SPAIN 132
10.3.6.1 Rising prevalence of hallux valgus to encourage growth 132
10.3.7 REST OF EUROPE 134
10.4 ASIA PACIFIC 136
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 139
10.4.2 CHINA 140
10.4.2.1 Growing public access to modern healthcare to fuel market growth 140
10.4.3 JAPAN 142
10.4.3.1 Rise in elderly population to support growth 142
10.4.4 INDIA 144
10.4.4.1 High prevalence of arthritis and foot deformities to encourage growth 144
10.4.5 REST OF ASIA PACIFIC 145
10.5 LATIN AMERICA 147
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 150
10.5.2 BRAZIL 151
10.5.2.1 Growing cultural focus on appearance to propel market 151
10.5.3 MEXICO 153
10.5.3.1 Increased availability of advanced surgical techniques to
augment growth 153
10.5.4 REST OF LATIN AMERICA 155
10.6 MIDDLE EAST & AFRICA 156
10.6.1 GROWING ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO PROPEL MARKET 156
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 158
10.7 GCC COUNTRIES 159
10.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET 159
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 161
11 COMPETITIVE LANDSCAPE 162
11.1 INTRODUCTION 162
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
BUNION SURGERY MARKET 162
11.3 REVENUE ANALYSIS, 2021–2023 164
11.4 MARKET SHARE ANALYSIS, 2023 165
11.5 COMPANY VALUATION AND FINANCIAL METRICS 167
11.6 BRAND/PRODUCT COMPARISON 168
11.6.1 SMITH+NEPHEW 168
11.6.2 ZIMMER BIOMET 168
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 169
11.7.1 STARS 169
11.7.2 EMERGING LEADERS 169
11.7.3 PERVASIVE PLAYERS 169
11.7.4 PARTICIPANTS 169
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 171
11.7.5.1 Company footprint 171
11.7.5.2 Region footprint 172
11.7.5.3 Product footprint 173
11.7.5.4 Patient type footprint 173
11.7.5.5 Type footprint 174
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 174
11.8.1 PROGRESSIVE COMPANIES 174
11.8.2 RESPONSIVE COMPANIES 174
11.8.3 DYNAMIC COMPANIES 174
11.8.4 STARTING BLOCKS 175
11.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023 176
11.8.5.1 Detailed list of key startups/SMEs 176
11.8.5.2 Competitive benchmarking of startups/SMEs 176
11.9 COMPETITIVE SCENARIO 177
11.9.1 PRODUCT LAUNCHES 177
11.9.2 DEALS 178
12 COMPANY PROFILES 179
12.1 KEY PLAYERS 179
12.1.1 STRYKER 179
12.1.1.1 Business overview 179
12.1.1.2 Products offered 180
12.1.1.3 Recent developments 182
12.1.1.3.1 Product launches 182
12.1.1.3.2 Deals 182
12.1.1.3.3 Expansions 182
12.1.1.3.4 Other developments 183
12.1.1.4 MnM view 183
12.1.1.4.1 Right to win 183
12.1.1.4.2 Strategic choices 183
12.1.1.4.3 Weaknesses and competitive threats 183
12.1.2 ZIMMER BIOMET 184
12.1.2.1 Business overview 184
12.1.2.2 Products offered 185
12.1.2.2.1 Deals 186
12.1.2.3 MnM view 186
12.1.2.3.1 Right to win 186
12.1.2.3.2 Strategic choices 186
12.1.2.3.3 Weaknesses and competitive threats 187
12.1.3 JOHNSON & JOHNSON SERVICES, INC. 188
12.1.3.1 Business overview 188
12.1.3.2 Products offered 189
12.1.3.3 Recent developments 190
12.1.3.3.1 Product launches 190
12.1.3.3.2 Deals 190
12.1.3.4 MnM view 190
12.1.3.4.1 Right to win 190
12.1.3.4.2 Strategic choices 191
12.1.3.4.3 Weaknesses and competitive threats 191
12.1.4 SMITH+NEPHEW 192
12.1.4.1 Business overview 192
12.1.4.2 Products offered 193
12.1.4.3 Recent developments 194
12.1.4.3.1 Deals 194
12.1.4.4 MnM view 194
12.1.4.4.1 Right to win 194
12.1.4.4.2 Strategic choices 194
12.1.4.4.3 Weaknesses and competitive threats 194
12.1.5 ENOVIS CORPORATION 195
12.1.5.1 Business overview 195
12.1.5.2 Products offered 196
12.1.5.3 Recent developments 197
12.1.5.3.1 Deals 197
12.1.5.3.2 Expansions 197
12.1.6 PARAGON 28, INC. 198
12.1.6.1 Business overview 198
12.1.6.2 Products offered 199
12.1.6.3 Recent developments 201
12.1.6.3.1 Product launches 201
12.1.6.3.2 Deals 201
12.1.6.4 MnM view 202
12.1.6.4.1 Right to win 202
12.1.6.4.2 Strategic choices 202
12.1.6.4.3 Weaknesses and competitive threats 202
12.1.7 TREACE MEDICAL CONCEPTS, INC. 203
12.1.7.1 Business overview 203
12.1.7.2 Products offered 204
12.1.7.3 Recent developments 205
12.1.7.3.1 Product launches 205
12.1.7.3.2 Deals 205
12.1.7.3.3 Other developments 206
12.1.8 CONMED CORPORATION 207
12.1.8.1 Business overview 207
12.1.8.2 Products offered 208
12.1.9 MEDARTIS AG 209
12.1.9.1 Business overview 209
12.1.9.2 Products offered 210
12.1.9.3 Recent developments 211
12.1.9.3.1 Product launches 211
12.1.9.3.2 Deals 211
12.1.10 DOUBLE MEDICAL TECHNOLOGY INC. 212
12.1.10.1 Business overview 212
12.1.10.2 Products offered 212
12.1.11 ARTHREX, INC. 213
12.1.11.1 Business overview 213
12.1.11.2 Products offered 213
12.1.11.3 Recent developments 214
12.1.11.3.1 Product launches 214
12.1.12 ACUMED LLC 215
12.1.12.1 Business overview 215
12.1.12.2 Products offered 215
12.1.12.3 Recent developments 216
12.1.12.3.1 Expansions 216
12.1.13 MERETE GMBH 217
12.1.13.1 Business overview 217
12.1.13.2 Products offered 217
12.1.14 VOOM MEDICAL DEVICES 218
12.1.14.1 Business overview 218
12.1.14.2 Products offered 218
12.1.15 BIOPRO, INC 219
12.1.15.1 Business overview 219
12.1.15.2 Products offered 219
12.2 OTHER PLAYERS 220
12.2.1 DIETER MARQUARDT MEDIZINTECHNIK GMBH 220
12.2.2 EXTREMITY MEDICAL 221
12.2.3 ASTROLABE 221
12.2.4 INVAMED 222
12.2.5 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES 222
12.2.6 AUXEIN 223
12.2.7 EXACTECH, INC. 223
12.2.8 JEIL MEDICAL CORPORATION 224
12.2.9 AYSAM ORTHOPAEDICS & MEDICAL DEVICES 224
12.2.10 DEVA TIBBI MALZEMELER 225
13 APPENDIX 226
13.1 DISCUSSION GUIDE 226
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 230
13.3 CUSTOMIZATION OPTIONS 232
13.4 RELATED REPORTS 232
13.5 AUTHOR DETAILS 233



List of Figures

FIGURE 1 BUNION SURGERY MARKETS COVERED AND REGIONAL SCOPE 25
FIGURE 2 BUNION SURGERY MARKET: RESEARCH DESIGN METHODOLOGY 28
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND
DEMAND-SIDE PARTICIPANTS 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 33
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 34
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 35
FIGURE 7 BUNION SURGERY MARKET: TOP-DOWN APPROACH 36
FIGURE 8 DATA TRIANGULATION METHODOLOGY 37
FIGURE 9 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 40
FIGURE 10 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION) 41
FIGURE 11 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 41
FIGURE 12 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 42
FIGURE 13 BUNION SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 43
FIGURE 14 INCREASING NUMBER OF BUNION SURGERIES TO DRIVE MARKET 44
FIGURE 15 IMPLANTS & ACCESSORIES SEGMENT TO LEAD MARKET
DURING FORECAST PERIOD 44
FIGURE 16 ADULT PATIENTS SEGMENT TO DOMINATE MARKET IN 2029 45
FIGURE 17 TRADITIONAL SURGERIES SEGMENT TO HAVE LARGEST MARKET SHARE
DURING FORECAST PERIOD 45
FIGURE 18 HOSPITALS SEGMENT TO COMMAND LARGEST MARKET SHARE
DURING FORECAST PERIOD 46
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
FIGURE 20 BUNION SURGERY MARKET: DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 47
FIGURE 21 NEW REVENUE POCKETS FOR PLAYERS IN BUNION SURGERY MARKET 52
FIGURE 22 BUNION SURGERY MARKET: VALUE CHAIN ANALYSIS 55
FIGURE 23 BUNION SURGERY MARKET: SUPPLY CHAIN ANALYSIS 56
FIGURE 24 BUNION SURGERY MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2018–2024 58
FIGURE 26 BUNION SURGERY MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024 60
FIGURE 27 BUNION SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 74
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 76
FIGURE 29 BUYING CRITERIA, BY PRODUCT 76
FIGURE 30 MARKET POTENTIAL OF AI IN BUNION SURGERY MARKET 78
FIGURE 31 NORTH AMERICA: BUNION SURGERY MARKET SNAPSHOT 115
FIGURE 32 ASIA PACIFIC: BUNION SURGERY MARKET SNAPSHOT 137
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN BUNION SURGERY MARKET, 2021–2023 164
FIGURE 34 BUNION SURGERY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 165
FIGURE 35 EV/EBITDA OF KEY VENDORS, 2024 167
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS, 2024 167
FIGURE 37 BUNION SURGERY MARKET: BRAND/PRODUCT COMPARISON 168
FIGURE 38 BUNION SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 170
FIGURE 39 BUNION SURGERY MARKET: COMPANY FOOTPRINT 171
FIGURE 40 BUNION SURGERY MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 175
FIGURE 41 STRYKER: COMPANY SNAPSHOT (2023) 180
FIGURE 42 ZIMMER BIOMET: COMPANY SNAPSHOT (2023) 185
FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023) 189
FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 193
FIGURE 45 ENOVIS CORPORATION: COMPANY SNAPSHOT (2023) 196
FIGURE 46 PARAGON 28, INC.: COMPANY SNAPSHOT (2023) 198
FIGURE 47 TREACE MEDICAL CONCEPTS, INC.: COMPANY SNAPSHOT (2023) 203
FIGURE 48 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 208
FIGURE 49 MEDARTIS AG: COMPANY SNAPSHOT (2023) 210

List of Tables

TABLE 1 BUNION SURGERY MARKET: INCLUSIONS AND EXCLUSIONS 26
TABLE 2 BUNION SURGERY MARKET: RISK ASSESSMENT 39
TABLE 3 FUNDING AND GRANTS IN BUNION SURGERY MARKET, 2021–2022 50
TABLE 4 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS, 2022–2024 53
TABLE 5 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS BY REGION, 2022–2024 54
TABLE 6 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS BY KEY PLAYER, 2024 (USD) 54
TABLE 7 BUNION SURGERY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 57
TABLE 8 BUNION SURGERY MARKET: INNOVATIONS AND PATENT REGISTRATIONS 2022–2023 61
TABLE 9 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD MILLION) 62
TABLE 10 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD MILLION) 62
TABLE 11 BUNION SURGERY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 63
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 65
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES 68
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS
AND MEDICAL DEVICES AGENCY 69
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 71
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 72
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 72
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 73
TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 73
TABLE 22 BUNION SURGERY MARKET: PORTER’S FIVE FORCES 74
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 76
TABLE 24 BUYING CRITERIA, BY PRODUCT 77
TABLE 25 BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 81
TABLE 26 KEY PRODUCTS IN IMPLANTS & ACCESSORIES MARKET 82
TABLE 27 BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY REGION 2022–2029 (USD MILLION) 82
TABLE 28 NORTH AMERICA: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES BY COUNTRY, 2022–2029 (USD MILLION) 83
TABLE 29 EUROPE: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES BY COUNTRY, 2022–2029 (USD MILLION) 83
TABLE 30 ASIA PACIFIC: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES BY COUNTRY, 2022–2029 (USD MILLION) 84
TABLE 31 LATIN AMERICA: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES BY COUNTRY, 2022–2029 (USD MILLION) 84
TABLE 32 KEY PRODUCTS IN CORRECTION SYSTEMS MARKET 85
TABLE 33 BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY REGION 2022–2029 (USD MILLION) 85
TABLE 34 NORTH AMERICA: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 85
TABLE 35 EUROPE: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 86
TABLE 36 ASIA PACIFIC: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 86
TABLE 37 LATIN AMERICA: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 87
TABLE 38 BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 89
TABLE 39 BUNION SURGERY MARKET FOR ADULT PATIENTS, BY REGION 2022–2029 (USD MILLION) 90
TABLE 40 NORTH AMERICA: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 90
TABLE 41 EUROPE: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY 2022–2029 (USD MILLION) 91
TABLE 42 ASIA PACIFIC: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 91
TABLE 43 LATIN AMERICA: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 92
TABLE 44 BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY REGION 2022–2029 (USD MILLION) 93
TABLE 45 NORTH AMERICA: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS BY COUNTRY, 2022–2029 (USD MILLION) 93
TABLE 46 EUROPE: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 47 ASIA PACIFIC: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 48 LATIN AMERICA: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 49 BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 96
TABLE 50 BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY REGION 2022–2029 (USD MILLION) 97
TABLE 51 NORTH AMERICA: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 52 EUROPE: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 53 ASIA PACIFIC: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 54 LATIN AMERICA: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 55 BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2022–2029 (USD MILLION) 100
TABLE 56 NORTH AMERICA: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 57 EUROPE: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 58 ASIA PACIFIC: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 59 LATIN AMERICA: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 60 BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 104
TABLE 61 BUNION SURGERY MARKET FOR HOSPITALS, BY REGION 2022–2029 (USD MILLION) 105
TABLE 62 NORTH AMERICA: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 63 EUROPE: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY 2022–2029 (USD MILLION) 106
TABLE 64 ASIA PACIFIC: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY 2022–2029 (USD MILLION) 106
TABLE 65 LATIN AMERICA: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY 2022–2029 (USD MILLION) 106
TABLE 66 BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION) 107
TABLE 67 NORTH AMERICA: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 68 EUROPE: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 69 ASIA PACIFIC: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 70 LATIN AMERICA: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 71 BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY REGION 2022–2029 (USD MILLION) 110
TABLE 72 NORTH AMERICA: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 73 EUROPE: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 74 ASIA PACIFIC: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 75 LATIN AMERICA: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 76 BUNION SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 77 NORTH AMERICA: BUNION SURGERY MARKET, BY COUNTRY 2022–2029 (USD MILLION) 116
TABLE 78 NORTH AMERICA: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 116
TABLE 79 NORTH AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 116
TABLE 80 NORTH AMERICA: BUNION SURGERY MARKET, BY TYPE 2022–2029 (USD MILLION) 117
TABLE 81 NORTH AMERICA: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 117
TABLE 82 NORTH AMERICA: NUMBER OF SURGERIES CONDUCTED, BY COUNTRY 2022–2029 117
TABLE 83 NORTH AMERICA: MACROECONOMIC INDICATORS 118
TABLE 84 US: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 119
TABLE 85 US: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 119
TABLE 86 US: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 119
TABLE 87 US: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 120
TABLE 88 CANADA: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 121
TABLE 89 CANADA: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 121
TABLE 90 CANADA: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 121
TABLE 91 CANADA: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 122
TABLE 92 EUROPE: BUNION SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 93 EUROPE: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 123
TABLE 94 EUROPE: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 123
TABLE 95 EUROPE: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 124
TABLE 96 EUROPE: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 124
TABLE 97 EUROPE: MACROECONOMIC INDICATORS 125
TABLE 98 GERMANY: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 126
TABLE 99 GERMANY: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 126
TABLE 100 GERMANY: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 126
TABLE 101 GERMANY: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 127
TABLE 102 UK: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 128
TABLE 103 UK: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 128
TABLE 104 UK: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 128
TABLE 105 UK: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 129
TABLE 106 FRANCE: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 129
TABLE 107 FRANCE: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 130
TABLE 108 FRANCE: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 109 FRANCE: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 130
TABLE 110 ITALY: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 131
TABLE 111 ITALY: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 131
TABLE 112 ITALY: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 132
TABLE 113 ITALY: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 132
TABLE 114 SPAIN: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 133
TABLE 115 SPAIN: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 133
TABLE 116 SPAIN: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 133
TABLE 117 SPAIN: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 134
TABLE 118 REST OF EUROPE: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 135
TABLE 119 REST OF EUROPE: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 135
TABLE 120 REST OF EUROPE: BUNION SURGERY MARKET, BY TYPE 2022–2029 (USD MILLION) 135
TABLE 121 REST OF EUROPE: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 136
TABLE 122 ASIA PACIFIC: BUNION SURGERY MARKET, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 123 ASIA PACIFIC: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 138
TABLE 124 ASIA PACIFIC: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 138
TABLE 125 ASIA PACIFIC: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 139
TABLE 126 ASIA PACIFIC: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 139
TABLE 127 ASIA PACIFIC: MACROECONOMIC INDICATORS 140
TABLE 128 CHINA: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 141
TABLE 129 CHINA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 141
TABLE 130 CHINA: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 141
TABLE 131 CHINA: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 142
TABLE 132 JAPAN: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 142
TABLE 133 JAPAN: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 143
TABLE 134 JAPAN: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 135 JAPAN: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 143
TABLE 136 INDIA: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 144
TABLE 137 INDIA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 145
TABLE 138 INDIA: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 145
TABLE 139 INDIA: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 145
TABLE 140 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 146
TABLE 141 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 146
TABLE 142 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY TYPE 2022–2029 (USD MILLION) 147
TABLE 143 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 147
TABLE 144 LATIN AMERICA: BUNION SURGERY MARKET, BY COUNTRY 2022–2029 (USD MILLION) 148
TABLE 145 LATIN AMERICA: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 148
TABLE 146 LATIN AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 149
TABLE 147 LATIN AMERICA: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 148 LATIN AMERICA: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 149
TABLE 149 LATIN AMERICA: MACROECONOMIC INDICATORS 150
TABLE 150 BRAZIL: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 151
TABLE 151 BRAZIL: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 152
TABLE 152 BRAZIL: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 152
TABLE 153 BRAZIL: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 152
TABLE 154 MEXICO: BUNION SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 153
TABLE 155 MEXICO: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 154
TABLE 156 MEXICO: BUNION SURGERY MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 157 MEXICO: BUNION SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 154
TABLE 158 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 155
TABLE 159 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 155
TABLE 160 REST OF LATIN AMERICA: BUNION TYPE MARKET, BY TYPE 2022–2029 (USD MILLION) 156
TABLE 161 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 156
TABLE 162 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 157
TABLE 163 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 157
TABLE 164 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY TYPE 2022–2029 (USD MILLION) 157
TABLE 165 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 158
TABLE 166 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 158
TABLE 167 GCC COUNTRIES: BUNION SURGERY MARKET, BY PRODUCT 2022–2029 (USD MILLION) 159
TABLE 168 GCC COUNTRIES: BUNION SURGERY MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 160
TABLE 169 GCC COUNTRIES: BUNION SURGERY MARKET, BY TYPE 2022–2029 (USD MILLION) 160
TABLE 170 GCC COUNTRIES: BUNION SURGERY MARKET, BY END USER 2022–2029 (USD MILLION) 160
TABLE 171 GCC COUNTRIES: MACROECONOMIC INDICATORS 161
TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
BUNION SURGERY MARKET, 2021–2024 162
TABLE 173 BUNION SURGERY MARKET: DEGREE OF COMPETITION 165
TABLE 174 BUNION SURGERY MARKET: REGION FOOTPRINT 172
TABLE 175 BUNION SURGERY MARKET: PRODUCT FOOTPRINT 173
TABLE 176 BUNION SURGERY MARKET: PATIENT TYPE FOOTPRINT 173
TABLE 177 BUNION SURGERY MARKET: TYPE FOOTPRINT 174
TABLE 178 BUNION SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 176
TABLE 179 BUNION SURGERY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 176
TABLE 180 BUNION SURGERY MARKET: PRODUCT LAUNCHES JANUARY 2021–NOVEMBER 2024 177
TABLE 181 BUNION SURGERY MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 178
TABLE 182 STRYKER: COMPANY OVERVIEW 179
TABLE 183 STRYKER: PRODUCTS OFFERED 180
TABLE 184 STRYKER: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 182
TABLE 185 STRYKER: DEALS, JANUARY 2021–NOVEMBER 2024 182
TABLE 186 STRYKER: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 182
TABLE 187 STRYKER: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 183
TABLE 188 ZIMMER BIOMET: COMPANY OVERVIEW 184
TABLE 189 ZIMMER BIOMET: PRODUCTS OFFERED 185
TABLE 190 ZIMMER BIOMET: DEALS, JANUARY 2021–NOVEMBER 2024 186
TABLE 191 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 188
TABLE 192 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 189
TABLE 193 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES JANUARY 2021–NOVEMBER 2024 190
TABLE 194 JOHNSON & JOHNSON: DEALS, JANUARY 2021–NOVEMBER 2024 190
TABLE 195 SMITH+NEPHEW: COMPANY OVERVIEW 192
TABLE 196 SMITH+NEPHEW: PRODUCTS OFFERED 193
TABLE 197 SMITH+NEPHEW: DEALS, JANUARY 2021–NOVEMBER 2024 194
TABLE 198 ENOVIS CORPORATION: COMPANY OVERVIEW 195
TABLE 199 ENOVIS CORPORATION: PRODUCTS OFFERED 196
TABLE 200 ENOVIS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 197
TABLE 201 ENOVIS CORPORATION: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 197
TABLE 202 PARAGON 28, INC.: COMPANY OVERVIEW 198
TABLE 203 PARAGON 28, INC.: PRODUCTS OFFERED 199
TABLE 204 PARAGON 28, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 201
TABLE 205 PARAGON 28, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 201
TABLE 206 TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW 203
TABLE 207 TREACE MEDICAL CONCEPTS, INC.: PRODUCTS OFFERED 204
TABLE 208 TREACE MEDICAL CONCEPTS, INC.: PRODUCT LAUNCHES JANUARY 2021–NOVEMBER 2024 205
TABLE 209 TREACE MEDICAL CONCEPTS, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 205
TABLE 210 TREACE MEDICAL CONCEPTS, INC.: OTHER DEVELOPMENTS JANUARY 2021–NOVEMBER 2024 206
TABLE 211 CONMED CORPORATION: COMPANY OVERVIEW 207
TABLE 212 CONMED CORPORATION: PRODUCTS OFFERED 208
TABLE 213 MEDARTIS AG: COMPANY OVERVIEW 209
TABLE 214 MEDARTIS AG: PRODUCTS OFFERED 210
TABLE 215 MEDARTIS AG: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 211
TABLE 216 MEDARTIS AG: DEALS, JANUARY 2021–NOVEMBER 2024 211
TABLE 217 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 212
TABLE 218 DOUBLE MEDICAL TECHNOLOGY INC.: PRODUCTS OFFERED 212
TABLE 219 ARTHREX, INC.: COMPANY OVERVIEW 213
TABLE 220 ARTHREX, INC.: PRODUCTS OFFERED 213
TABLE 221 ARTHREX, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 214
TABLE 222 ACUMED LLC: COMPANY OVERVIEW 215
TABLE 223 ACUMED LLC: PRODUCTS OFFERED 215
TABLE 224 ACUMED LLC: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 216
TABLE 225 MERETE GMBH: COMPANY OVERVIEW 217
TABLE 226 MERETE GMBH: PRODUCTS OFFERED 217
TABLE 227 VOOM MEDICAL DEVICES: COMPANY OVERVIEW 218
TABLE 228 VOOM MEDICAL DEVICES: PRODUCTS OFFERED 218
TABLE 229 BIOPRO, INC.: COMPANY OVERVIEW 219
TABLE 230 BIOPRO, INC.: PRODUCTS OFFERED 219
TABLE 231 DIETER MARQUARDT MEDIZINTECHNIK GMBH: COMPANY OVERVIEW 220
TABLE 232 EXTREMITY MEDICAL: COMPANY OVERVIEW 221
TABLE 233 ASTROLABE: COMPANY OVERVIEW 221
TABLE 234 INVAMED: COMPANY OVERVIEW 222
TABLE 235 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES: COMPANY OVERVIEW 222
TABLE 236 AUXEIN: COMPANY OVERVIEW 223
TABLE 237 EXACTECH, INC.: COMPANY OVERVIEW 223
TABLE 238 JEIL MEDICAL CORPORATION: COMPANY OVERVIEW 224
TABLE 239 AYSAM ORTHOPAEDICS & MEDICAL DEVICES: COMPANY OVERVIEW 224
TABLE 240 DEVA TIBBI MALZEMELER: COMPANY OVERVIEW 225